Literature DB >> 23637302

Emergence of a new norovirus GII.4 variant and changes in the historical biennial pattern of norovirus outbreak activity in Alberta, Canada, from 2008 to 2013.

Maria E Hasing1, Bonita E Lee, Jutta K Preiksaitis, Raymond Tellier, Lance Honish, Ambikaipakan Senthilselvan, Xiaoli L Pang.   

Abstract

The public health impact of the emergence of new norovirus (NoV) strains is uncertain. A biennial pattern of alternating quiescent and epidemic levels of NoV outbreak activity associated with the emergence of new GII.4 variants was observed in Alberta, Canada, between July 2000 and June 2008. In this study, NoV genogroup I (GI) and GII strains isolated from 710 outbreak specimens in Alberta between July 2008 and January 2013 were characterized to update historical data. The seasonality and annual variation in NoV outbreak burden were analyzed over a 10-year period (July 2002 to June 2012). We found that GII.4-2006b had persisted as the predominant variant over three observation periods (July 2006 to June 2009) during which the biennial NoV outbreak pattern continued. The emergence of GII.4-2010 (winter 2009) was not associated with increased outbreak activity, and outbreak activity between July 2009 and June 2012 when GII.4-2010 predominated (67.5 to 97.7%) did not follow a biennial pattern. GII.4-2012 first emerged in Alberta in September 2011 and became predominant in observation period July 2012 to June 2013. NoV GI, relatively rare in past years, had a higher activity level (37.3%) as represented by GI.6 and GI.7 in the winter of 2012 to 2013. A higher proportion of GI outbreaks occurred in non-health care facility settings compared to GII. Our study suggests that factors other than new variants emergence contribute to the levels of NoV outbreak activity in Alberta.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23637302      PMCID: PMC3697663          DOI: 10.1128/JCM.00663-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Noroviruses in healthcare settings: a challenging problem.

Authors:  M Koopmans
Journal:  J Hosp Infect       Date:  2009-09-22       Impact factor: 3.926

2.  Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006.

Authors:  Du-Ping Zheng; Marc-Alain Widdowson; Roger I Glass; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

3.  Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States.

Authors:  Catherine Yen; Mary E Wikswo; Ben A Lopman; Jan Vinje; Umesh D Parashar; Aron J Hall
Journal:  Clin Infect Dis       Date:  2011-08-10       Impact factor: 9.079

4.  Assessing seasonality in clinical research.

Authors:  Ton J Cleophas; Aeilko H Zwinderman
Journal:  Clin Chem Lab Med       Date:  2012-12       Impact factor: 3.694

5.  Updated norovirus outbreak management and disease prevention guidelines.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2011-03-04

6.  Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995.

Authors:  J S Noel; T Ando; J P Leite; K Y Green; K E Dingle; M K Estes; Y Seto; S S Monroe; R I Glass
Journal:  J Med Virol       Date:  1997-12       Impact factor: 2.327

7.  Rapid evolution of pandemic noroviruses of the GII.4 lineage.

Authors:  Rowena A Bull; John-Sebastian Eden; William D Rawlinson; Peter A White
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

Review 8.  Norovirus gastroenteritis.

Authors:  Roger I Glass; Umesh D Parashar; Mary K Estes
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

Review 9.  Viral shape-shifting: norovirus evasion of the human immune system.

Authors:  Eric F Donaldson; Lisa C Lindesmith; Anna D Lobue; Ralph S Baric
Journal:  Nat Rev Microbiol       Date:  2010-02-02       Impact factor: 60.633

10.  Emergence of new norovirus strain GII.4 Sydney--United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-25       Impact factor: 17.586

View more
  26 in total

1.  Environmental Surveillance for Noroviruses in Selected South African Wastewaters 2015-2016: Emergence of the Novel GII.17.

Authors:  V V Mabasa; K D Meno; M B Taylor; Janet Mans
Journal:  Food Environ Virol       Date:  2017-08-04       Impact factor: 2.778

2.  New strains of norovirus and the mystery of viral gastroenteritis epidemics.

Authors:  Bonita E Lee; Xiao-Li Pang
Journal:  CMAJ       Date:  2013-09-03       Impact factor: 8.262

3.  The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.

Authors:  John-Sebastian Eden; Joanne Hewitt; Kun Lee Lim; Maciej F Boni; Juan Merif; Gail Greening; Rodney M Ratcliff; Edward C Holmes; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Virology       Date:  2013-12-25       Impact factor: 3.616

4.  Slow Clearance of Norovirus following Infection with Emerging Variants of Genotype GII.4 Strains.

Authors:  Lars Gustavsson; Rickard Nordén; Johan Westin; Magnus Lindh; Lars-Magnus Andersson
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

5.  RNA populations in immunocompromised patients as reservoirs for novel norovirus variants.

Authors:  Everardo Vega; Eric Donaldson; Jeremy Huynh; Leslie Barclay; Ben Lopman; Ralph Baric; Luke F Chen; Jan Vinjé
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 6.  Epidemiology of human noroviruses and updates on vaccine development.

Authors:  Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

7.  Genetic analysis of the capsid region of norovirus GII.4 variants isolated in South Korea.

Authors:  Ju-Eun Kim; Sung-Geun Lee; Han-Gil Cho; Sang-Ha Han; Lae-Hyung Kang; Youn-Mi Lee; Chul-Jong Park; Soon-Young Paik
Journal:  J Microbiol       Date:  2014-04-11       Impact factor: 3.422

Review 8.  Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.

Authors:  Eunüs S Ali; Harinda Rajapaksha; Jillian M Carr; Nikolai Petrovsky
Journal:  Antiviral Res       Date:  2016-07-13       Impact factor: 5.970

9.  Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.

Authors:  Sreejesh Shanker; Rita Czako; Banumathi Sankaran; Robert L Atmar; Mary K Estes; B V Venkataram Prasad
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

10.  Norovirus Disease in Older Adults Living in Long-Term Care Facilities: Strategies for Management.

Authors:  Yingxi Chen; Aron J Hall; Martyn D Kirk
Journal:  Curr Geriatr Rep       Date:  2017-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.